Kristen Douglas

Kristen Koterba Douglas is currently an Associate Director of Bioprocess Development at Vir Biotechnology. She obtained a B.S. in Biology and a minor in Chemistry from the University of Texas. She holds a Ph.D. in Molecular and Cell Biology from the Medical College of Ohio where she studied cancer biology and developed novel methods to detect protein-protein interactions using bioluminescence resonance energy transfer. In 2009 she was hired as a post-doc at Genentech and published on the role of thioredoxin in antibody disulfide bond reduction in cell culture processes. She then joined Genentech full time in the Late Stage Cell Culture department as a scientist and group leader and supported multiple late stage development and process characterization programs that led to successful commercial licensure. She has been at Vir for the last 2.5 years leading process development efforts for recombinant antibodies and viral vectors as well as tech transfer to external CMOs.